#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3298	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2424	404.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1886	1886	T	446	T,G	383,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3298	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2424	404.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1620	1620	C	519	C,A	417,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3298	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2424	404.1	0	HET	.	.	.	A69G	.	69	69	A	505	505	A	499	A,G	326,92	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3298	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2424	404.1	0	HET	.	.	.	G642A	.	642	642	G	1078	1078	G	513	G,A	337,93	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5186	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3792	408.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1808	1808	A	433	A	358	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5186	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3792	408.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2442	2442	C	466	C	391	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5186	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3792	408.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2516	2516	A	477	A	391	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5186	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3792	408.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3068	3068	C	438	C	359	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	384	folP	852	852	99.88	folP.l15.c4.ctg.1	1909	60.1	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1004	1006	AAA	84;84;85	A,C;A,C;A	66,1;66,1;64	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	384	folP	852	852	99.88	folP.l15.c4.ctg.1	1909	60.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1235	1237	AGC	87;87;87	A;G;C	70;70;68	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1004	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3753	80.2	1	SNP	p	S91F	0	.	.	271	273	TCC	778	780	TCC	90;90;89	T,G;C;C	67,1;69;70	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1004	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3753	80.2	1	SNP	p	D95G	0	.	.	283	285	GAC	790	792	GAC	86;85;85	G;A;C	70;64;70	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1004	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3753	80.2	1	SNP	p	D95N	0	.	.	283	285	GAC	790	792	GAC	86;85;85	G;A;C	70;64;70	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	452	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1658	81.9	1	SNP	p	G45D	0	.	.	133	135	GGC	652	654	GGC	112;112;113	G;G;C	92;94;94	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	292	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1266	68.9	0	.	n	.	0	A197.	DEL	197	197	A	717	717	A	128	A	107	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3269	95.6	1	SNP	p	D86N	0	.	.	256	258	GAC	740	742	GAC	109;109;110	G;A;C	87;82;86	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3269	95.6	1	SNP	p	S87I	0	.	.	259	261	AGT	743	745	AGT	109;110;109	A,G;G;T	83,1;89;82	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3269	95.6	1	SNP	p	S87R	0	.	.	259	261	AGT	743	745	AGT	109;110;109	A,G;G;T	83,1;89;82	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3269	95.6	1	SNP	p	S87W	0	.	.	259	261	AGT	743	745	AGT	109;110;109	A,G;G;T	83,1;89;82	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3269	95.6	1	SNP	p	S88P	0	.	.	262	264	TCC	746	748	TCC	109;109;109	T;C;C	84;87;89	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	880	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2952	89.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1710	1712	GGC	117;117;117	G,T;G,T;C	98,1;98,1;98	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1466	1468	GCA	119;119;118	G;C;A,C	93;93;93,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1469	1471	ATC	118;118;118	A;T;C,A	95;85;89,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1481	1483	GTG	119;119;119	G,C;T,G;G	96,1;92,1;97	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1481	1483	GTG	119;119;119	G,C;T,G;G	96,1;92,1;97	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1985	1987	ACC	68;68;68	A;C;C	54;57;59	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2039	2041	GCG	65;64;64	G;C,T;G	54;48,1;49	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2039	2041	GCG	65;64;64	G;C,T;G	54;48,1;49	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2162	2164	GGC	86;86;86	G;G;C	69;71;72	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2171	2173	GGC	85;84;84	G;G,T;C	70;69,1;68	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	790	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2725	86.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2189	2191	CTG	91;91;92	C;T;G	74;75;74	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1224	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3405	107.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1862	1864	CCG	96;97;97	C;C;G,T	81;81;80,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	566	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2212	76.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	734	734	C	83	C	68	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	610	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1801	99.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	535	537	GAA	119;120;120	G;A;A	98;99;99	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	610	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1801	99.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	823	825	GAT	111;112;111	G;A;T	88;89;91	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	610	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1801	99.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	946	948	TCA	118;118;117	T;C;A	85;85;86	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	610	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1801	99.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1075	1077	GTC	126;126;126	G;T;C	105;107;106	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	610	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1801	99.5	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1087	1089	TCT	125;124;124	T;C;T	110;108;108	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	610	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1801	99.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1405	1407	GCA	132;133;133	G;C,A;A	117;112,1;110	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	610	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1801	99.5	1	SNP	p	G120K	1	.	.	358	360	AAG	781	783	AAG	108;108;108	A;A;G	92;91;91	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	610	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1801	99.5	1	SNP	p	D121N	0	.	.	361	363	GAC	784	786	GAC	108;111;111	G;A;C	91;91;92	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	610	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1801	99.5	1	SNP	p	A121D	1	.	.	361	363	GAC	784	786	GAC	108;111;111	G;A;C	91;91;92	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2018	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5167	117.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2121	2123	AAT	118;119;118	A;A;T,G	94;98;97,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	356	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1300	82.0	1	SNP	p	V57M	1	.	.	169	171	ATG	704	706	ATG	145;146;145	A;T,G;G	116;115,1;117	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
